NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED

Clinical trials for NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED explained in plain language.

Never miss a new study

Get alerted when new NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED trials appear

Sign up with your email to follow new studies for NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental cell therapy offers hope for lymphoma patients out of options

Disease control Recruiting now

This early-stage study is testing the safety of a new cell therapy called CD19 t-haNK for adults with non-Hodgkin lymphoma that has returned or hasn't responded to previous treatments. The study will enroll 20 participants to test the therapy alone and in combination with two oth…

Matched conditions: NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED

Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Apr 02, 2026 03:41 UTC

NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED

Get alerted when new NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED trials appear

Experimental cell therapy offers hope for lymphoma patients out of options